Company intelligence / Profile preview

Taizhou Langrun Pharmaceutical

Taizhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Taizhou Langrun Pharmaceutical is a Chinese pharmaceutical company based in the Linhai Coastal Industrial Zone of Taizhou, Zhejiang. The company specializes in the research, development, and large-scale manufacturing of active pharmaceutical ingredients (APIs) and chemical intermediates. Its product portfolio primarily focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-infectives. Operating with GMP-compliant facilities, the company serves both domestic and international markets through the supply of high-quality chemical precursors and finished APIs.

Therapeutic areas: EndocrinologyInfectious DiseasesCardiovascular
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Taizhou Langrun Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taizhou Langrun Pharmaceutical.

Explore the full profile